| Drug Repurposing for the Treatment of Mycobacterium abscessus Infections EJ Baker, A Molloy, JAG Cox Infectious Microbes & Diseases 5 (3), 101-110, 2023 | 4 | 2023 |
| Do variations in nasal irrigation recipes and storage effect the risk of bacterial contamination? JD Whittaker, E Baker, S Kumar, R Collingwood, M West, PK Lee The Journal of Laryngology & Otology 137 (7), 794-798, 2023 | 2 | 2023 |
| Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery EJ Baker, G Allcott, JAG Cox npj Antimicrobials and Resistance 2 (1), 38, 2024 | | 2024 |
| Aryl‐Fluorocyclopropane β‐Lactams with Activity Against Mycobacteroides abscessus and Mycobacterium bovis BCG DE Spurling, EJ Baker, G Kingsley‐Moore, RMN Ppadath, ND More, ... European Journal of Organic Chemistry, e202401050, 2024 | | 2024 |
| Cystic fibrosis sputum media induces an overall loss of antibiotic susceptibility in Mycobacterium abscessus EJ Baker, G Allcott, A Molloy, JAG Cox npj Antimicrobials and Resistance 2 (1), 34, 2024 | | 2024 |
